-
3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech
- October 21, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Mid-cap Pharma Growth Stocks with a strong future roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Brand and Ingredient Stocks with a strong future roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.